According to filings with the U.S. Securities and Exchange Commission, NanoImaging Services is raising $6,000,000.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Janine Leblanc played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About NanoImaging Services
Visualizing biomolecular structures through cryo-EM studies can provide insight into multiple stages of the drug development process, from target identification through formulation and manufacturing. As the industry leader with the longest history in cryo-EM, and with more cryo-EM scientists and TEM microscopes than any provider in North America, NIS is focused on three areas of cutting-edge science: – Target Enablement, using high resolution single particle analysis for structure-based drug design. -Characterization, which includes complete morphology assessment to inform size, shape, uniformity, aggregation, purify, and cargo description, with quantitative analysis. -Small molecule MicroED, which provides high resolution structures of challenging samples. Diverse skill sets and state-of-the art technology help us make cryo-EM accessible to companies of all sizes, and to teams across the drug discovery pipeline. Through collaboration, learning, and a commitment to quality results, we help our clients accelerate the development of new and life changing therapeutics.

To learn more about NanoImaging Services, visit http://www.nanoimagingservices.com/

Contact:
Janine Leblanc, Chief Financial Officer
858-552-8538

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.